AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLINDAMYCIN PALMITATE HYDROCHLORIDE
5 registrations across 3 African markets— 3 active
Markets with CLINDAMYCIN PALMITATE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AUCIN SUSPENSION | 🇬🇭Ghana | — | active | Jul 2030 |
| AUCIN SUSPENSION | 🇬🇭Ghana | — | active | Jul 2030 |
| DALACIN C PALMITATE GRANULE, FOR SUSPENSION; ORAL | 🇿🇼Zimbabwe | PFIZER LABORATORIES (PTY) LTD | active | Dec 2027 |
| DALACIN-C 75MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Jun 2007 |
| DALACIN-C 75MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Jun 2003 |
CLINDAMYCIN PALMITATE HYDROCHLORIDE in Africa — Regulatory Overview
CLINDAMYCIN PALMITATE HYDROCHLORIDE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 3 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.